British drugmaker AstraZeneca wants U.S. regulators to authorize its new antibody drug for emergency use. The drug could be an alternative to vaccination.
AstraZeneca Seeks Approval for COVID-19 Drug
By Don Ma
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.